Shares of ImmunoGen Inc. jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with Takeda...
Shares of ImmunoGen Inc.
jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with Takeda Pharmaceutical Co. Ltd. TAK, +0.59% 4502, +0.52% to commercialize its Elahere ovarian cancer treatment in Japan. Under terms of the collaboration, ImmunoGen will receive an upfront payment of $34 million, and will be eligible to receive additional payments as the U.S.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Narcan donation to Cook County coming after CBS 2 reportOver 2,000 life-saving overdose devices are being donated to the Cook County Sheriff's Office, and it's all because a pharmaceutical company saw a story on CBS 2.
Lire la suite »
1 Stock to Buy, 1 Stock to Sell This Week: Salesforce, Dollar GeneralStocks Analysis by Investing.com (Jesse Cohen) covering: Salesforce Inc, Dollar General Corporation. Read Investing.com (Jesse Cohen)'s latest article on Investing.com
Lire la suite »
CEO Who Fired Employees Via Zoom Sees Stock Crash SpectacularlyBetter.com went public Wednesday in a SPAC merger gone terribly wrong. Its CEO isn’t getting much sympathy.
Lire la suite »
Stock Buybacks Harm Workers and CustomersCEOs argue they just don’t have the money to hire more workers or pay family-supporting wages. But their actions say something else.
Lire la suite »
Nvidia Plans to Buy Back Billions in Stock. Other Companies Could Join in Soon.Buybacks can often be a key ingredient to stock market returns for investors.
Lire la suite »